KalVista Pharmaceuticals (NASDAQ:KALV) CEO Sells $120,423.94 in Stock
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV - Get Free Report) CEO Benjamin Palleiko sold 7,294 shares of the firm's stock in a transaction dated Monday, December 8th. The shares were sold at an...